


| jCyte Inc. : Enters into Ex-US Licensing and Commercialization Agreement for jCell Therapy with Global Ophthalmology Leader Santen Pharmaceutical |
|
jCyte to receive up to $252 million, inclusive of $50 million in upfront cash, $12 million in a convertible note offering, and milestone payments of up to $190 million in potential milestones in Europe, Asia and Japan, as well as tiered, double-digit royalties on net commercial sales for jCell in all regions outside the U.
Posted: 2020-05-08 14:17:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.